Navigation Links
MZ Group to Sponsor Asia BiotechInvest 2013 Conference
Date:5/7/2013

SAN DIEGO, May 7, 2013 /PRNewswire/ -- MZ Group ("MZ"), the world's largest independent investor relations and corporate communications firm, today announced its participation as a supporting partner at the inaugural Asia BiotechInvest 2013 Conference ("Conference") being held on June 3rd to June 5th, 2013, at the Sheraton Hotel & Towers in Hong Kong.

MZ works with top companies in Asia, Australia, Canada, Latin America, and the U.S. to support their clients' investor relations and corporate communications needs in four distinct product and service categories: IR Consulting & Outreach – traditional investor relations and roadshow services; iMarketing & Social Media – lead generation and harvesting services and social media relations; Market Intelligence – real time ownership monitoring; Technology Services – corporate websites, video, distribution services, conference calls, IRNavigatorTM, and more. 

MZ also serves as an information resource for over 75,000 institutional investors, brokers, analysts, high net worth individuals, and retail investors to provide real-time, unbiased and comprehensive information.

Ted Haberfield , President of MZ North America stated, "We look forward to a successful experience at Asia BiotechInvest 2013. As interest in compelling investment opportunities within the life sciences sector continues to grow globally, we have proactively expanded our outreach efforts to more events in Asia and Australia. Consistent with other events organized by AusBiotech, we expect another productive conference attended by high quality companies and investors."

Asia BiotechInvest 2013 provides an ideal forum for emerging life science companies based in the Asia Pacific region to present their investment story to analysts, institutional investors, venture capitalists and private equity firms in Hong Kong. The general presentations, Q&A sessions, and panel discussions provide opportunities for investors and management teams to learn more about company and industry developments. Asia BiotechInvest is organized by AusBiotech, a leading industry group in Australia focused on promoting global growth of the Australian biotech industry, and Beacon, a global conference and exhibition organizer.

To register online please click on the following link:
https://www.beaconevents.com/2013/AsiaBiotechInvest2013/en/forms/registration2_step2.jsp

About MZ Group

The MZ Group is a multinational company and the world's largest independent financial communication, corporate communications, IPO journey, market intelligence and applied technology for corporations. Founded in 1999, MZ focuses on innovation and personalized services, supported by its exclusive "one‐stop‐shop" business model. With offices in São Paulo, Chicago, Hong Kong, New York, Beijing, San Diego, Shanghai, Sydney, and Taipei, MZ has approximately 330 professionals who serve over 500 clients in 11 countries. For more information please visit www.mzgroup.us.

About AusBiotech

AusBiotech is Australia's industry organization, working on behalf of members for more than 25 years to provide representation and services to promote the global growth of Australian biotechnology. AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural, environmental and industrial sectors.

AusBiotech is dedicated to the development, growth and prosperity of the Australian biotechnology industry, by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world.

For more information, visit www.ausbiotech.org.

Cautionary Note Regarding Forward Looking Statements

This press release contains forward-looking statements regarding future events and financial performance. In some cases, you can identify these statements by words such as "may," "might," "will," "should," "except," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential," or "continue," the negative of these terms and other comparable terminology. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond control. There are or may be important factors that could cause actual results to materially differ from historical results or from any future results expressed or implied by such forward looking statements.

Contacts:
MZ North America
Ted Haberfield , President
Tel: +1-760-755-2716
thaberfield@mzgroup.us
www.mzgroup.us


'/>"/>
SOURCE MZ Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
2. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
3. BioNeutral Group Receives $400,000 in Equity Financing
4. MiMedx Group Completes $5,000,000 Private Placement
5. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
6. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
7. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
8. Statewide Network of Angel Investor Groups Announced in Alabama
9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
10. Weikang Bio-Technology Group Co., Inc. Is Expected to Achieve the Net Profit of at Least $26 Million
11. MiMedx Group Announces 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 A person commits a crime, and the ... track the criminal down. An outbreak of foodborne ... Administration (FDA) uses DNA evidence to track down the bacteria ... far-fetched? It,s not. The FDA has increasingly used a complex, ... foodborne illnesses. Put as simply as possible, whole genome sequencing ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
Breaking Biology News(10 mins):